Principal Investigator: Ben Blount / Maocheng (Tony) Yang
Funding Mechanism: Interagency Agreement
ID number: 224-10-9022
Award Date: 1/1/2011
Institution: Centers for Disease Control and Prevention
Establishing baseline levels of exposure to harmful and potentially harmful constituents (HPHCs) in tobacco products may help establish the relationship between HPHC levels and consumer risk. Using a variety of new analytical methods, the laboratory will analyze urine samples from adult, non-institutionalized, civilian, self-identified smokers in order to establish baseline biomarker levels. This baseline data may be used to inform manufacturer application review, development of product standards and other regulatory activities.